BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21417822)

  • 1. Immunoconjugates in the management of hairy cell leukemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Recombinant Immunotoxins for Hairy Cell Leukemia.
    Kreitman RJ; Pastan I
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32756468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.
    Grever MR; Abdel-Wahab O; Andritsos LA; Banerji V; Barrientos J; Blachly JS; Call TG; Catovsky D; Dearden C; Demeter J; Else M; Forconi F; Gozzetti A; Ho AD; Johnston JB; Jones J; Juliusson G; Kraut E; Kreitman RJ; Larratt L; Lauria F; Lozanski G; Montserrat E; Parikh SA; Park JH; Polliack A; Quest GR; Rai KR; Ravandi F; Robak T; Saven A; Seymour JF; Tadmor T; Tallman MS; Tam C; Tiacci E; Troussard X; Zent CS; Zenz T; Zinzani PL; Falini B
    Blood; 2017 Feb; 129(5):553-560. PubMed ID: 27903528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat hairy cell leukemia.
    Grever MR
    Blood; 2010 Jan; 115(1):21-8. PubMed ID: 19843881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia.
    Marvin-Peek J; Jen WY; Kantarjian HM; McCue D; Haddad FG; Wierda W; Ferrajoli A; Burger J; Abusab T; Jorgensen J; Wang SA; Patel K; Loghavi S; O'Brien S; Ravandi F
    Leuk Lymphoma; 2024 May; ():1-10. PubMed ID: 38749022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant.
    Liu Q; Harris N; Epperla N; Andritsos LA
    Onco Targets Ther; 2021; 14():1797-1805. PubMed ID: 33727830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxetumomab Pasudotox: Clinical Experience in Relapsed/Refractory Hairy Cell Leukemia.
    Feurtado J; Kreitman RJ
    Clin J Oncol Nurs; 2019 Jun; 23(3):E52-E59. PubMed ID: 31099793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia: short review, today's recommendations and outlook.
    Maevis V; Mey U; Schmidt-Wolf G; Schmidt-Wolf IG
    Blood Cancer J; 2014 Feb; 4(2):e184. PubMed ID: 24531447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
    Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H
    Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy for hairy cell leukemia.
    Ravandi F
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):230-5. PubMed ID: 26614901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of minimal residual disease in hairy cell leukemia.
    Ravandi F; Jorgensen JL; O'Brien SM; Verstovsek S; Koller CA; Faderl S; Giles FJ; Ferrajoli A; Wierda WG; Odinga S; Huang X; Thomas DA; Freireich EJ; Jones D; Keating MJ; Kantarjian HM
    Blood; 2006 Jun; 107(12):4658-62. PubMed ID: 16497968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping.
    Tallman MS
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():65-8. PubMed ID: 21463116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC).
    López Rubio M; Da Silva C; Loscertales J; Seri C; Baltasar P; Colado E; Pérez Fernández I; Osma M; Gomis F; González M; Jarque I; Vargas M; Monzó E; Monteagudo D; Orts MI; Pardal E; Carbonell F; Perez Calvo C; Garcia-Marco JA
    Leuk Lymphoma; 2014 May; 55(5):1007-12. PubMed ID: 23885799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-immunotherapy for hairy cell leukemia.
    Ravandi F
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2(0 2):72-4. PubMed ID: 21417822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.